Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FP7AL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,945
Award facts
- Contract value 100% obligated
- $4,944.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,944.93 by the Defense Logistics Agency for the supply of Entyvio 300 mg vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 25, 2025. This award was issued without a set-aside designation, demonstrating the contractor's competitive positioning in federal pharmaceutical procurement markets.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at $499.999 billion and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide. Entyvio is a biologic medication used in the treatment of inflammatory bowel diseases, and this delivery order represents one of numerous pharmaceutical procurement actions the contractor fulfills for the Department of Defense healthcare supply chain. DMS Pharmaceutical Group's established role as a key supplier within DLA's pharmaceutical distribution network reflects its significance in supporting medical supply operations across military health facilities.
Quick answers
Who was awarded contract SPE2DB25FP7AL?
SPE2DB25FP7AL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FP7AL worth?
The government has obligated $4,945 on SPE2DB25FP7AL.
Is contract SPE2DB25FP7AL an order under another contract?
Yes. SPE2DB25FP7AL is a delivery order under SPE2DB22D9311, an indefinite delivery contract.
Was contract SPE2DB25FP7AL competed?
The extent of competition for SPE2DB25FP7AL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award